Cognitive Impairment in Kidney Disease

NCT ID: NCT00905619

Last Updated: 2017-08-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

117 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-12-01

Study Completion Date

2017-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An increasing number of Veterans are anticipated to develop chronic kidney disease (CKD) and require hemodialysis (HD) treatments as the Veteran population ages. In 2003, approximately 290,000 US citizens were receiving HD and an estimated 19 million were affected by CKD. The annual growth rate is predicted to be 7% per year with 500,000 Americans receiving HD treatment by 2010. In 2005, approximately 2500 Veterans were receiving HD with growth expected to parallel that seen in the general population. Whereas Alzheimer's disease is the leading cause of dementia in the general population, growing evidence suggests that patients with advanced CKD experience cognitive deficits related to accelerated cerebrovascular disease. Patients with advanced CKD have been shown to have a high prevalence of sub-clinical cerebrovascular damage on imaging studies and a heavy burden of vascular risk factors such as diabetes, elevated cholesterol, and hypertension. Many of the cognitive deficits related to cerebrovascular disease may go unrecognized by routine measures of cognition. HD patients have increased number of hospitalizations, and several compliance issues ranging from congestive heart failure to dangerous electrolyte imbalances. Impaired cognition in this population is likely to have a significant impact on self-care and compliance with complex medical regimens. Currently, the severity and scope of cognitive impairment related to vascular disease is not well known in patients with advanced kidney disease. Additionally, the relationship between cognitive impairment and measures of self-care independence are not well known. Loss of independence and function secondary to impaired cognitive function is likely to be a significant problem for patients with advanced kidney disease. Early identification of functional impairment, particularly instrumental activities of daily living (IADL), will allow for rehabilitation intervention. Maintaining or improving functional independence through intensive rehabilitation could translate into better compliance and lower hospitalization rate among HD patients. Information obtained from this study is likely to heighten awareness of cognitive impairment and the functional consequences in Veterans with advanced kidney disease. Primary objectives are to determine:

1. The range of cognitive deficits with emphasis on domains affected by vascular disease in patients with advanced CKD and those receiving hemodialysis.
2. The associations between severity of cognitive impairment and severity of kidney disease.
3. The prevalence of impaired IADLs and the level of health-related quality of life (HRQOL) in patients with advanced CKD and those requiring hemodialysis.
4. The relationship or association of cognitive impairment with IADL and HRQOL.

Secondary objective is to determine:

1\. The relationships among cerebral and carotid blood flow, carotid artery stiffness, and renal specific metabolic abnormalities with cognitive impairment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Insufficiency, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

No kidney disease

No interventions assigned to this group

PreHD kidney disease

Kidney disease stage 4 or below

No interventions assigned to this group

Hemodialysis

Kidney disease receiving hemodialysis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

PreHD Subjects:

* Male or female with an age of 18 years or older (no upper limit);
* Patients with stage III-IV CKD attending the renal primary care clinic or renal consult clinic;
* Fluent in English;
* Outpatient or stable nursing home patient

HD Subjects:

* Receiving HD for at least two weeks;
* Male or female with an age of 18 years or older (no upper limit);
* Fluent in English;
* Outpatient or stable nursing home patient

Control Subjects:

* Glomerular filtration rate of 60 cc/minute or greater;
* Male or female with an age of 18y or older (no upper limit);
* Fluent in English
* Outpatient

Exclusion Criteria

PreHD Subjects:

* Acute illness;
* Clinical history of stroke, dementia, or Parkinson's disease;
* Hb \<10;
* Liver function tests 2x upper limit of normal;
* Hemodialysis

HD Subjects:

* Acute illness;
* Clinical history of stroke, dementia, or Parkinson's disease;
* Hb \<10;
* Liver function tests 2x upper limit of normal;
* URR \<65% (measure of dialysis adequacy: will use 3-month average from chart)

Control Subjects:

* Acute illness;
* Clinical history of stroke, dementia, or Parkinson's disease;
* Hb \<10;
* Liver function tests 2x upper limit of normal;
* Stage 3-4 CKD;
* Hemodialysis
Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James B Post, MD

Role: PRINCIPAL_INVESTIGATOR

James J. Peters Veterans Affairs Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

James J. Peters VA Medical Center, Bronx, NY

The Bronx, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Post JB, Jegede AB, Morin K, Spungen AM, Langhoff E, Sano M. Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract. 2010;116(3):c247-55. doi: 10.1159/000317206. Epub 2010 Jul 2.

Reference Type RESULT
PMID: 20606486 (View on PubMed)

Post JB, Morin KG, Handrakis JP, Rivera DR, Yen C, Sano M, Spungen AM. Cognition may be related to arterial pulsatility index in HD patients. Clin Nephrol. 2014 May;81(5):313-9. doi: 10.5414/cn107998.

Reference Type RESULT
PMID: 24780553 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B5050W-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BRINK (BRain In Kidney Disease) Memory Study 2.0
NCT04975464 ACTIVE_NOT_RECRUITING
Safe Kidney Care Cohort Study
NCT01407367 COMPLETED
Primary Care CKD Registry
NCT03473509 COMPLETED NA
Preventing Acute Kidney Injury
NCT04376619 WITHDRAWN NA